Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Consequences of disruption of the interaction between p53 and the larger adenovirus early region 1B protein in adenovirus E1 transformed human cells

Oncogene volume 19, pages 452–462 (2000)Cite this article

Abstract

The adenovirus early region 1B (Ad E1B) genes have no transforming capability of their own but markedly increase the transformation frequency of Ad E1A following co-transfection into mammalian cells. The larger E1B proteins of both Ad2/5 and Ad12 bind to p53 and inhibit its ability to transcriptionally activate other genes. We have previously demonstrated that synthetic peptides identical to the binding sites for p53 on both the Ad2 and Ad12 E1B proteins will disrupt the interaction in vivo and in vitro. In the work presented here we have examined the effects of complex dissociation on Ad E1-transformed human cells. It has been shown, using confocal microscopy, that when the peptide identical to the p53 binding site was added to Ad5 E1-transformed cells it initally located in the cytoplasmic dense bodies where it caused disruption of the p53/E1B complex. Peptide and p53 then translocated to the nucleus. In Ad12 E1-transformed cells the peptide localized in the nucleus directly and there caused a re-organization of p53 staining from a highly organized, `flecked' distribution to one in which nuclear staining was homogeneous and diffuse. Peptides added to either Ad5 E1 or Ad12 E1 transformed cells resulted in the release of transcriptionally active p53. Interestingly, the level of p53 then fell presumably as a result of proteasomal action - this was probably a reflection of the short half-life of `free' (i.e. dissociated) p53 compared to that of the bound protein. Free p53 did not cause apoptosis in target cells probably due to the presence of the smaller (19K) E1B proteins. However, addition of peptide leads to a significant reduction in cell growth rate. We have further demonstrated that a significant proportion of those cells which had taken up peptide had ceased DNA synthesis, probably due to a p53-induced cell cycle arrest. The role of the larger E1B protein during transformation is considered in view of these data.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Bayley ST and Mymryk JS. . 1994 Int. J. Onc. 5: 425–444.

  • Bernards R and van der Eb AJ. . 1984 Biochim. Biophys. Acta. 783: 187–204.

  • Blair-Zejdal ME and Blair GE. . 1988 Oncogene 2: 579–584.

  • Chinnadurai G. . 1998 Sems Virol. 8: 399–408.

  • Chiou S-K and White E. . 1997 J. Virol. 71: 3515–3525.

  • Debbas M and White E. . 1993 Genes Dev. 7: 546–554.

  • Derossi D, Chassaing G and Prochiantz A. . 1998 Trends Cell. Biol. 8: 84–87.

  • de Stanchina E, McCurrach ME, Zindy F, Shieh S-Y, Ferbeyre G, Samuelson AV, Prives C, Roussel MF, Sherr CJ and Lowe SW. . 1998 Genes Dev. 12: 2434–2442.

  • Dobbelstein M, Roth J, Kimberly WT, Levine AJ and Shenk T. . 1997 EMBO J. 16: 4276–4284.

  • Gabler S, Schutt H, Groit IP, Wolf H, Shenk T and Dobner T. . 1998 J. Virol. 72: 7960–7971.

  • Gallimore PH, Byrd PJ and Grand RJA. . 1985a Soc. Gen. Micobiol. Symp. 37: 125–172.

  • Gallimore PH, Byrd PJ, Whittaker JL and Grand RJA. . 1985b Cancer Res. 45: 2670–2680.

  • Gallimore PH, Grand RJA and Byrd PJ. . 1986 Anticancer Res. 6: 499–508.

  • Gallimore PH, Lecane PS, Roberts S, Rookes SM, Grand RJA and Parkhill J. . 1997 J. Virol. 6629–6640.

  • Grand RJA, Lecane PS, Roberts S, Grant ML, Lane DP, Young LS, Dawson CW and Gallimore PH. . 1993 Virology 193: 579–591.

  • Grand RJA, Grant ML and Gallimore PH. . 1994 Virology 203: 229–240.

  • Grand RJA, Owen D, Rookes SM and Gallimore PH. . 1996 Virology 218: 23–34.

  • Grand RJA, Parkhill J, Szestak T, Rookes SM, Roberts S and Gallimore PH. . 1999 Oncogene 18: 955–965.

  • Huen DS, Henderson SA, Croom-Carter D and Rowe M. . 1995 Oncogene 10: 549–560.

  • Kern SE, Pietenpol JA, Thiagalingam S, Seymour A, Kinzler KW and Vogelstein B. . 1992 Science 256: 827–830.

  • Lowe SW and Ruley HE. . 1993 Genes Dev. 7: 535–545.

  • Mak I, Mak S and Benchimol S. . 1988 Virology 163: 201–204.

  • Merrick RM, Grand RJA, Brown JC and Gallimore PH. . 1991 J. Gen. Virol. 72: 955–960.

  • Moran E. . 1994 Sems. Virol. 5: 327–340.

  • Querido E, Teodoro JG and Branton PE. . 1997 J. Virol. 71: 3526–3533.

  • Prochiantz A. . 1996 Curr. Opin. Neurobiol. 6: 629–634.

  • Rao L, Debbas M, Sabbatini P, Hockenbery D, Korsmeyer S and White E. . 1992 Proc. Natl. Acad. Sci. USA 89: 7742–7746.

  • Sarnow P, Ho YS, Williams J and Levine A. . 1982 Cell 28: 387–394.

  • Thomas A and White E. . 1998 Genes Dev. 12: 1975–1985.

  • Turnell AS, Grand RJA and Gallimore PH. . 1999 J. Virol. 73: 2074–2083.

  • van den Heuval SJL, van Laar T, Kast WM, Melief CJM, Zantema A and van der Eb AJ. . 1990 EMBO J. 9: 2621–2629.

  • White E. . 1998 Sem. Virol. 8: 505–513.

  • White E. . 1996 Genes Dev. 10: 1–15.

  • Yew PR and Berk AJ. . 1992 Nature 357: 82–85.

  • Yew PR, Liu X and Berk AJ. . 1994 Genes Dev. 8: 190–202.

  • Zantema A, Schrier PI, Davis-Olivier A, van Laar T, Vaessen RTMJ and van der Eb AJ. . 1985a Mol. Cell. Biol. 5: 3084–3091.

  • Zantema A, Fransen JAM, Davis-Olivier A, Ramaekers FCS, Vooijs GP, de Leys B and van der Eb AJ. . 1985b Virology 142: 44–58.

Download references

Acknowledgements

We are most grateful to Susan Rookes, Institute for Cancer Studies, for help with some of the experiments, to Katja Schmeiser for invaluable advice on confocal microscopy and Professors David Lane and Arnold Levine for gift of antibodies. We also thank Nicola Waldron for excellent secretarial help, and the Cancer Research Campaign and Medical Research Council for financial support.

Author information

Authors and Affiliations

  1. CRC Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK

    Fiona G Hutton, Andrew S Turnell, Phillip H Gallimore & Roger JA Grand

Authors
  1. Fiona G Hutton
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrew S Turnell
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Phillip H Gallimore
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Roger JA Grand
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hutton, F., Turnell, A., Gallimore, P. et al. Consequences of disruption of the interaction between p53 and the larger adenovirus early region 1B protein in adenovirus E1 transformed human cells. Oncogene 19, 452–462 (2000). https://doi.org/10.1038/sj.onc.1203316

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203316

Keywords

This article is cited by

Search

Advanced search

Quick links